Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PRN.TOthis companyProfound Medical Corp.	CA$10.17	-5.48×	3.58×	14.48×	-4.4×	-580.0%	70.8%	-256.3%	-264.4%	-65.3%	-31.1%	-16.5%	0.07×	1.33×	0×	12.52×	0.0%	3	4.37	1	C-
CRRX.TOCareRx Corporation	CA$3.11	9.1×	2.19×	0.65×	10.63×	374.7%	25.0%	3.2%	7.1%	23.9%	6.0%	9.2%	0.71×	2.23×	1.74×	1.06×	0.5%	5	1.17	4	A
CYBN.NECybin Inc.	CA$12.78	-1.59×	1.01×	0×	-0.54×	-62.3%	0.0%	0.0%	0.0%	-63.2%	-60.9%	-57.1%	0×	1.11×	-48.88×	9.52×	0.0%	3	8.63	2	C
DR.TOMedical Facilities Corporation	CA$15.34	10.6×	2.99×	0.87×	3.81×	67.8%	38.0%	18.4%	8.2%	28.0%	19.5%	18.2%	0.78×	0.24×	13.23×	1.79×	2.3%	8	2.15	4	A
EPRX.TOEupraxia Pharmaceuticals Inc.	CA$9.96	-9.83×	5.04×	0×	-8.54×	-78.4%	0.0%	0.0%	0.0%	-47.9%	-48.6%	-7.2%	0×	2.07×	0×	15.12×	0.0%	2	34.16	2	C
HLS.TOHLS Therapeutics Inc.	CA$4.50	-8.77×	1.8×	1.96×	8.25×	26.6%	42.5%	-7.4%	-22.4%	-20.5%	-3.5%	14.3%	0.81×	2.11×	-0.58×	1.11×	0.0%	5	-1.12	2	C+
Peer median	—	-1.59×	2.19×	0.65×	3.81×	26.6%	25.0%	0.0%	0.0%	-20.5%	-3.5%	9.2%	0.71×	2.07×	0×	1.79×	0.0%	5	2.15	2	—